Keyword: Corden Pharma

News

CordenPharma Invests €900 Million in Peptide Platform Expansion

16.07.2024 -

CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.

News

CordenPharma Expands Early Clinical Peptide Manufacturing in Germany

07.03.2024 -

CordenPharma has commissioned new GMP capacities at its site in Frankfurt, Germany to manufacture early clinical phase peptide APIs for pharma and biotech customers. The...

News

CordenPharma & pHLIP Form RNA & Gene Delivery Alliance

08.01.2024 -

CordenPharma and pHLIP have announced their strategic alliance to collaborate in developing and commercializing the pHLIP-LNP targeted delivery platform for RNA-based and...

News

CordenPharma Completes Upgrade of US Peptide Production Site in Colorado

06.09.2023 -

CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide...

News

CordenPharma Expands at US Site in Colorado

04.05.2023 -

CordenPharma is expanding strategically into synthetic oligonucleotide manufacturing at its plant at Boulder in the US state of Colorado. The two-phase investment is...

News

Wacker and CordenPharma in RNA Drugs Project

04.04.2023 -

Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), German companies Wacker Chemie and CordenPharma International...

News

CordenPharma Lifts xRNA Capability in Italy

13.06.2022 -

German CDMO CordenPharma, a specialist in Active Pharmaceutical Ingredients (APIs), excipients, drug products and packaging services (APIs), is investing more than €10...

News

Astorg to Acquire CordenPharma from ICIG

04.05.2022 -

Private equity investor Astorg has signed a binding agreement with International Chemical Investors Group (ICIG) to acquire Plankstadt, Germany-based CDMO CordenPharma...